Isabelle Sermet-Gaudelus

17PUBLICATIONS
104CO-AUTHORS
Data and information privacyInfant and child healthCondensed matter characterisation technique developmentCarbon capture engineering (excl. sequestration)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 08, 2026
Mental health safety profile of CFTR modulators in pediatrics and adults: insights from the French pharmacovigilance database and from VigiBase.

|Aug 31, 2026
Continuous glucose monitoring to track metabolic changes in youths with cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor therapy.

|Jun 18, 2026
Persistence of lung hyperinflation and small airway dysfunction in school-aged children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: results from the real-world MODUL-CF study.

|May 21, 2025
Newborn Screening for Cystic Fibrosis Is Associated With the Lowest Healthcare Costs: A 10-Year Observational Follow-Up Study in France.

Erika Guyot, Floriane Deygas, Manon Belhassen

|Mar 06, 2025
Beyond the Lung. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Sinonasal Disease in Children With Cystic Fibrosis.

Margaux Petitjean, Alexia Letierce, Anne-Sophie Bonnel

|Feb 20, 2025
Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Adolescents With Cystic Fibrosis.

Alfonso Galderisi, Laurence Weiss, Alix Besançon

Pageof 3

Frequent Collaborators

4 joint publications

Pierre-Régis Burgel

4 joint publications

Philippe Reix

3 joint publications

Clémence Martin

3 joint publications

Emmanuelle Girodon